公司概述
Westlake Chemical Partners LP operates within the Basic Materials sector, specifically focusing on the Chemicals industry by acquiring, developing, and operating ethylene production facilities across the United States. These facilities primarily function by converting ethane into ethylene, while the entity also generates and sells valuable co-products such as propylene, crude butadiene, and pyrolysis gasoline. The company's current market capitalization stands at $795.50 million, supported by an annual revenue of $1.17 billion, reflecting its significant scale as a mid-sized player in the specialty chemicals market. While the specific employee count is not disclosed in available data, the combination of substantial revenue and a market cap under one billion suggests a mature operational footprint that serves as a critical component of the broader petrochemical supply chain.
财务健康
The company reported a trailing twelve-month revenue of $1.17 billion, accompanied by a net income of $48.70 million and an EBITDA of $447.56 million. The substantial disparity between the $1.17 billion revenue figure and the $48.70 million net income reveals a cost structure where operating expenses and taxes consume approximately 95.8% of top-line earnings, leaving a profit margin of only 4.2%. However, the generation of $314.19 million in free cash flow demonstrates strong financial flexibility, indicating that the business model effectively converts operations into distributable cash or capital for reinvestment. Profitability efficiency is further highlighted by a gross margin of 29.8% and an operating margin of 27.8%, which signify that the company retains significant value after direct production costs and overheads before arriving at the final net profit. The balance sheet shows $44.27 million in cash against $399.67 million in total debt, resulting in a debt-to-equity ratio of 49.81, which characterizes a leveraged financial position rather than a conservative one. Despite the leverage, a current ratio of 2.80 indicates robust short-term liquidity, suggesting the firm holds nearly three times the current assets required to cover its immediate liabilities. Management effectiveness is underscored by a Return on Equity (ROE) of 36.6% and a Return on Assets (ROA) of 15.7%, metrics that demonstrate the ability to generate high returns relative to the capital employed and the total asset base.
估值评估
Valuation metrics indicate a trailing P/E ratio of 16.36 and a forward P/E of 12.16, implying that the market expects earnings growth to occur in the future as the forward multiple is significantly lower than the historical average. The price-to-book ratio sits at 1.59, indicating that the market values the company at a 59% premium over its net book value, which often reflects intangible assets or future growth potential not fully captured on the balance sheet. Alternative valuation measures, including a price-to-sales ratio of 0.68 and an EV/EBITDA of 3.25, suggest the company trades at a discount relative to sales and earnings multiples typically seen in more cyclical or high-growth chemical peers. The stock has traded between a 52-week low of $17.75 and a 52-week high of $23.82; without the specific current share price in the provided facts, the precise percentage distance from these extremes cannot be calculated, though the range defines the recent volatility floor and ceiling. A beta of 0.55 indicates that the stock's price volatility is less than half that of the broader market, suggesting it behaves as a defensive position relative to the overall equity market.
Growth & Income
Revenue growth for the trailing twelve months stands at 11.4%, while earnings growth registered a decline of 4.7% year-over-year, implying that earnings are currently growing slower than revenue, likely due to the aforementioned thin net profit margins and potentially fixed cost pressures. As a high-yield entity, the company offers a dividend yield of 8.3%, but this must be contextualized by a payout ratio of 136.6%, which exceeds the trailing earnings generation. A payout ratio above 100% generally suggests that dividends are being funded by cash flow, reserves, or debt rather than current period earnings, raising questions about long-term sustainability without improvements in profitability. The overall growth and income profile presents a dichotomy of strong top-line expansion and high cash conversion capabilities contrasted with a leveraged balance sheet and a dividend yield that relies on cash flow rather than distributable earnings.